National Pension Service Raises Holdings in Kenvue Inc. (NYSE:KVUE)

Key Points

• The National Pension Service increased its holdings in Kenvue Inc. by 2.3%, now owning about 2.89 million shares valued at approximately $69.2 million.
• Kenvue recently declared a quarterly dividend of $0.2075 per share, which is a slight increase from the previous dividend of $0.21, representing an annual yield of 3.9%.
• Despite exceeding earnings estimates with a reported $0.29 earnings per share, Kenvue's revenue declined by 4.0% year-over-year, totaling $3.84 billion.

National Pension Service raised its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 2.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,885,918 shares of the company's stock after acquiring an additional 64,762 shares during the quarter. National Pension Service owned approximately 0.15% of Kenvue worth $69,204,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Pittenger & Anderson Inc. acquired a new stake in shares of Kenvue in the 1st quarter valued at about $30,000. TruNorth Capital Management LLC acquired a new stake in Kenvue during the 1st quarter worth approximately $36,000. Clal Insurance Enterprises Holdings Ltd lifted its position in Kenvue by 378.5% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company's stock worth $39,000 after acquiring an additional 1,287 shares during the period. Bank Julius Baer & Co. Ltd Zurich raised its stake in shares of Kenvue by 120.6% during the 1st quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,699 shares of the company's stock worth $41,000 after buying an additional 929 shares in the last quarter. Finally, Clarity Asset Management Inc. purchased a new position in shares of Kenvue during the 4th quarter worth approximately $45,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Kenvue Stock Down 3.0%

KVUE opened at $21.06 on Friday. The business's fifty day moving average is $21.55 and its two-hundred day moving average is $22.42. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. The company has a market cap of $40.41 billion, a price-to-earnings ratio of 28.45, a PEG ratio of 3.12 and a beta of 0.83. Kenvue Inc. has a one year low of $19.75 and a one year high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%. Kenvue's revenue was down 4.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.32 earnings per share. Analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th will be given a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, August 13th. This is a positive change from Kenvue's previous quarterly dividend of $0.21. This represents a $0.83 annualized dividend and a yield of 3.9%. Kenvue's dividend payout ratio (DPR) is 112.16%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on KVUE shares. Canaccord Genuity Group cut their target price on Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Bank of America cut their target price on Kenvue from $27.00 to $25.00 and set a "buy" rating for the company in a research note on Tuesday, July 15th. Barclays cut their target price on Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a research note on Tuesday, July 15th. JPMorgan Chase & Co. cut their target price on Kenvue from $27.00 to $26.00 and set an "overweight" rating for the company in a research note on Friday, July 25th. Finally, Citigroup reduced their price objective on Kenvue from $24.50 to $22.00 and set a "neutral" rating for the company in a report on Tuesday, July 15th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Kenvue presently has an average rating of "Hold" and an average target price of $24.38.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.